FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013485309> ?p ?o ?g. }

• W3013485309 endingPage "2295" @default.
• W3013485309 startingPage "2295" @default.
• W3013485309 abstract "A previous study reported that relatively high-dose cilostazol (0.3%) promoted the drainage of cerebrovascular amyloid-β (Aβ) protein in Aβ Precursor Protein (APP) transgenic mice overexpressing vasculotropic Aβ. We investigated whether lower-dose cilostazol can decrease micro-hemorrhages and Aβ deposition in the brain using APP transgenic mice. At baseline, 14-month-old female Tg2576 mice were randomly assigned to a control group (vehicle), aspirin group (0.01% aspirin), or cilostazol group (0.01% cilostazol). The severity of cerebral micro-hemorrhages (i.e., number), area of senile plaque, and severity of vascular amyloid burden (quantified with cerebral amyloid angiopathy (CAA) score (=number of Aβ-positive vessels × severity of amyloid burden of Aβ-positive vessels) were evaluated in the brain of mice aged 15 and 21–23 months. At 15 months, no differences were shown in each pathological change among the three groups. At 21–23 months, there were no differences in the severity of cerebral micro-hemorrhages or area of senile plaque among the three groups. However, the CAA score was significantly lower in the cilostazol compared to the control group (p = 0.046, Mann–Whitney U test), although no difference was seen between the control and aspirin group. Our study showed that lower-dose cilostazol could reduce the vascular amyloid burden without increasing cerebral micro-hemorrhages in APP transgenic mice." @default.
• W3013485309 created "2020-04-03" @default.
• W3013485309 creator A5006805979 @default.
• W3013485309 creator A5012293531 @default.
• W3013485309 creator A5013792551 @default.
• W3013485309 creator A5016713260 @default.
• W3013485309 creator A5019632697 @default.
• W3013485309 creator A5035202189 @default.
• W3013485309 creator A5053093501 @default.
• W3013485309 creator A5065318724 @default.
• W3013485309 creator A5081041527 @default.
• W3013485309 date "2020-03-26" @default.
• W3013485309 modified "2023-10-18" @default.
• W3013485309 title "Low-Dose Phosphodiesterase III Inhibitor Reduces the Vascular Amyloid Burden in Amyloid-β Protein Precursor Transgenic Mice" @default.
• W3013485309 cites W1574564357 @default.
• W3013485309 cites W1619610860 @default.
• W3013485309 cites W1855009337 @default.
• W3013485309 cites W1870043354 @default.
• W3013485309 cites W1929267935 @default.
• W3013485309 cites W1966030100 @default.
• W3013485309 cites W1971593160 @default.
• W3013485309 cites W1971796751 @default.
• W3013485309 cites W1972186270 @default.
• W3013485309 cites W1972509721 @default.
• W3013485309 cites W1981711337 @default.
• W3013485309 cites W1983670592 @default.
• W3013485309 cites W1994183414 @default.
• W3013485309 cites W2000834296 @default.
• W3013485309 cites W2020094709 @default.
• W3013485309 cites W2023092313 @default.
• W3013485309 cites W2027814917 @default.
• W3013485309 cites W2028084402 @default.
• W3013485309 cites W2044546031 @default.
• W3013485309 cites W2048099169 @default.
• W3013485309 cites W2062626127 @default.
• W3013485309 cites W2068731335 @default.
• W3013485309 cites W2091766797 @default.
• W3013485309 cites W2099884864 @default.
• W3013485309 cites W2108216694 @default.
• W3013485309 cites W2126266889 @default.
• W3013485309 cites W2147388177 @default.
• W3013485309 cites W2148035614 @default.
• W3013485309 cites W2196088104 @default.
• W3013485309 cites W2280755676 @default.
• W3013485309 cites W2292136218 @default.
• W3013485309 cites W2304307857 @default.
• W3013485309 cites W2329336071 @default.
• W3013485309 cites W2340238654 @default.
• W3013485309 cites W2922465750 @default.
• W3013485309 cites W4296816736 @default.
• W3013485309 doi "https://doi.org/10.3390/ijms21072295" @default.
• W3013485309 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7177305" @default.
• W3013485309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32225099" @default.
• W3013485309 hasPublicationYear "2020" @default.
• W3013485309 type Work @default.
• W3013485309 sameAs 3013485309 @default.
• W3013485309 citedByCount "5" @default.
• W3013485309 countsByYear W30134853092020 @default.
• W3013485309 countsByYear W30134853092021 @default.
• W3013485309 countsByYear W30134853092022 @default.
• W3013485309 crossrefType "journal-article" @default.
• W3013485309 hasAuthorship W3013485309A5006805979 @default.
• W3013485309 hasAuthorship W3013485309A5012293531 @default.
• W3013485309 hasAuthorship W3013485309A5013792551 @default.
• W3013485309 hasAuthorship W3013485309A5016713260 @default.
• W3013485309 hasAuthorship W3013485309A5019632697 @default.
• W3013485309 hasAuthorship W3013485309A5035202189 @default.
• W3013485309 hasAuthorship W3013485309A5053093501 @default.
• W3013485309 hasAuthorship W3013485309A5065318724 @default.
• W3013485309 hasAuthorship W3013485309A5081041527 @default.
• W3013485309 hasBestOaLocation W30134853091 @default.
• W3013485309 hasConcept C102230213 @default.
• W3013485309 hasConcept C104317684 @default.
• W3013485309 hasConcept C126322002 @default.
• W3013485309 hasConcept C134018914 @default.
• W3013485309 hasConcept C141035611 @default.
• W3013485309 hasConcept C142724271 @default.
• W3013485309 hasConcept C185592680 @default.
• W3013485309 hasConcept C2777628954 @default.
• W3013485309 hasConcept C2777633098 @default.
• W3013485309 hasConcept C2777790613 @default.
• W3013485309 hasConcept C2779134260 @default.
• W3013485309 hasConcept C2779483572 @default.
• W3013485309 hasConcept C2779820409 @default.
• W3013485309 hasConcept C31705614 @default.
• W3013485309 hasConcept C502032728 @default.
• W3013485309 hasConcept C55493867 @default.
• W3013485309 hasConcept C68026918 @default.
• W3013485309 hasConcept C71924100 @default.
• W3013485309 hasConcept C90924648 @default.
• W3013485309 hasConcept C98274493 @default.
• W3013485309 hasConceptScore W3013485309C102230213 @default.
• W3013485309 hasConceptScore W3013485309C104317684 @default.
• W3013485309 hasConceptScore W3013485309C126322002 @default.
• W3013485309 hasConceptScore W3013485309C134018914 @default.
• W3013485309 hasConceptScore W3013485309C141035611 @default.
• W3013485309 hasConceptScore W3013485309C142724271 @default.
• W3013485309 hasConceptScore W3013485309C185592680 @default.

• next